Early Molecular Events in the Development of the Diabetic Cardiomyopathy
Overview
Affiliations
Unlabelled: Oxidative damage to DNA has been well documented in cardiac cells isolated from diabetic patients and rats with streptozotocin-induced diabetes mellitus (DM). This study evaluates possible molecular mechanisms for early events in the development of DM-induced cardiomyopathy.
Methods: To analyze the mechanism of overexpression of p21(WAF1/CIP1) and inhibition of cyclin D(1) expression in cardiomyocytes of diabetic rats we examined the methylation status of these genes by MS-PCR and assessed the possibility of epigenetic control of their expression.
Results: We found that the steady-state expression of both genes is influenced by their methylation status, as an epigenetic event, of their 5'-flanking regions upon development of diabetes.
Conclusions: Oxidative damage contributes to the development of cardiomyopathy via p53-dependent activation of cardiac cell death. This pathway includes de novomethylation of the P53-inducible p21(WAF1/CIP1)-gene encoding a protein which binds to and inhibits a broad range of cyclin-cyclin-dependent kinase complexes.
Jazieh C, Arabi T, Asim Z, Sabbah B, Alsaud A, Alkattan K Front Endocrinol (Lausanne). 2024; 15:1295967.
PMID: 38323108 PMC: 10845351. DOI: 10.3389/fendo.2024.1295967.
Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.
Cai L, Tan Y, Holland B, Wintergerst K Cardiovasc Toxicol. 2024; 24(2):71-84.
PMID: 38321349 PMC: 11517829. DOI: 10.1007/s12012-024-09836-7.
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes.
Ryaboshapkina M, Ye R, Ye Y, Birnbaum Y Cardiovasc Drugs Ther. 2023; 39(1):43-61.
PMID: 37914900 DOI: 10.1007/s10557-023-07517-1.
Epigenetics of methylation modifications in diabetic cardiomyopathy.
Hao J, Liu Y Front Endocrinol (Lausanne). 2023; 14:1119765.
PMID: 37008904 PMC: 10050754. DOI: 10.3389/fendo.2023.1119765.
Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy.
da Silva J, Goncalves R, Vasques J, Rocha B, Nascimento-Carlos B, Montagnoli T Cells. 2022; 11(2).
PMID: 35053356 PMC: 8773977. DOI: 10.3390/cells11020240.